| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesiology, Université Catholique de Louvain School of Medicine, St Luc Hospital, Brussels, Belgium; and
Department of Anesthesiology, Cliniques St Pierre, Ottignies, Belgium
Address correspondence and reprint requests to F.J. Singelyn, MD, PhD, Department of Anesthesiology, St Luc Hospital, Avenue Hippocrate 10/1821-B 1200, Brussels, Belgium.
| Abstract |
|---|
|
|
|---|
Implications: This study demonstrated that, after total hip arthroplasty, an extended femoral nerve sheath block consisting of patient-controlled analgesia boluses (5 mL per 30 min) of 0.125% bupivacaine with clonidine 1 µg/mL and sufentanil 0.1 µg/mL provides efficient postoperative analgesia and significantly minimizes local anesthetic consumption.
| Introduction |
|---|
|
|
|---|
The continuous infusion of 0.125% bupivacaine at the rate of 10 mL/h is effective to maintain extended femoral nerve sheath block (6). However, this technique leads to the administration of large volumes of local anesthetic with a potential risk of toxicity caused by accumulation of the drug after a prolonged period of infusion (8). A dose-sparing infusion technique is thus desirable. For example, after hand trauma surgery, a PCA technique via an axillary brachial plexus catheter provides good postoperative analgesia and reduces local anesthetic consumption by 70% (9). This technique has not yet been evaluated with a femoral nerve sheath catheter. The aim of the present study was to assess its efficacy after unilateral THA.
| Methods |
|---|
|
|
|---|
In all patients, a femoral nerve sheath block was performed before the induction of general anesthesia by using the landmarks of Winne et al. (10). The femoral artery was located below the inguinal ligament, and a 6-cm, 18-gauge, short-beveled, insulated needle through a plastic cannula (Alphaplex® set; Braun, Melsungen, Germany) was inserted just lateral to the artery. The femoral nerve was accurately located with a peripheral nerve stimulator (pulse duration, 40 µs; frequency, 1 Hz) (Anaestim MK III®; Meda, Antwerpen, Belgium). With a starting output of 100 nanocoulombs (nC) (2.5 mA), the needle was advanced with an angle of 3045° to the skin until twitches of the quadriceps muscle (ascension of the patella) were elicited. Its position was then optimized and judged adequate when output lower than 40 nC (<1 mA) still elicited quadriceps contractions. By using a Seldinger technique, a 20-gauge catheter was then threaded 1015 cm into the femoral nerve sheath. After a negative aspiration test for blood, 40 mL 0.25% bupivacaine with epinephrine 1:200,000 was injected through the catheter.
In all patients, general anesthesia was induced with 0.3 µg/kg sufentanil, 35 mg/kg thiopental, and 0.5 mg/kg atracurium. The trachea was intubated, and controlled ventilation was started. Anesthesia was maintained with a sufentanil infusion (0.005 µg · kg1 · min1 stopped approximately 45 min before the end of the procedure) and a mixture of nitrous oxide (66%) and isoflurane (0.5%1%) in oxygen.
In all patients, ketorolac 30 mg IV was administered at the induction of general anesthesia and then three times daily during the first 48 h after surgery.
Thromboprophylaxis was given routinely with low-molecular-weight heparin, i.e., 7500 (<70 kg) or 10,000 (>70 kg) units nadroparin (Fraxiparine®; Sanofi-Winthrop, New York, NY) subcutaneously, and antiplatelet drug, i.e., 600 mg buflomédil (Loftyl®; Abbott, North Chicago, IL) PO, once daily, starting the evening of surgery.
In the recovery room, the correct position of the femoral nerve sheath catheter was confirmed by the presence of a sensory block (loss of cold sensation as assessed by using an ether-soaked swab) involving the distribution of the femoral nerve (anterior aspect of the thigh). Patients were then divided into three groups of 15 in a randomized fashion with a computer-generated list of random permutations. During the first 48 h after surgery, Group 1 received a continuous infusion of 0.125% bupivacaine with clonidine 1 µg/mL and sufentanil 0.1 µg/mL at the rate of 10 mL/h, Group 2 had PCA boluses only of 10 mL of the same solution with a lockout time of 60 min, and Group 3 had PCA boluses only of 5 mL of the same solution with a lockout time of 30 min. To blind the study, patients in Group 1 also had access to a PCA button, but it did not trigger any bolus administration.
Pain at rest and on movement (visual analog scale [VAS] ranging from 0 = no pain to 100 = worst pain imaginable) and sensory block (loss of temperature sensation assessed by using an ether-soaked swab) in the cutaneous distribution of the lateral femoral cutaneous (LFC) (lateral aspect of the thigh), femoral (anterior aspect of the thigh), and obturator (inner aspect of the knee) nerves were assessed 4, 24, and 48 h after the operation. A postoperative pain score (PPS) (0 = no pain; 1 = moderate pain only when moving; 2 = moderate pain at rest, severe pain when moving; 3 = constant severe pain) was also recorded by the nurses every 2 h during the first 12 h after surgery and then every 4 h. Supplemental postoperative analgesia was standardized. If PPS was
1, patients received 2 g of IV propacetamol, a derivative of paracetamol (Prodafalgan®; Upsamedica, Brussels, Belgium), followed by 1020 mg of IM piritramide, a synthetic µ-agonist opioid (Dipidolor®; Janssen Pharmaceutica, Beerse, Belgium) if PPS remained unchanged after 30 min. Supplemental analgesia, bupivacaine consumption, side effects, and satisfaction score (with a VAS ranging from 0 = not satisfied to 100 = entirely satisfied) at the end of the study period were recorded. All data were collected by an anesthesiologist not involved in the administration of anesthesia or in patient care in the recovery room.
The patients were seen at the surgeons clinic 6 wk and 3 mo after the procedure. They were then asked about any adverse effects or complications.
On the basis of a previous study (11), we hypothesized that we could observe at least a 30% reduction in the consumption of bupivacaine between Groups 1 and 2. A power analysis (mean consumption of 500 [Group 1] and 350 [Group 2] mg of bupivacaine with a standard deviation of 80 mg) estimated that 10 patients would be needed in each group to provide a 95% chance of detecting such reduction at the 0.01 level of significance.
Statistical analysis was performed with the GB-Stat, version 6.5 (Dynamic Microsystems, Inc., Silver Spring, MD) computer package. Parametric data (age, weight, height, pain scores, supplemental analgesia, bupivacaine consumption, and satisfaction score) were compared by using one-way analysis of variance. Post hoc comparisons were performed with Dunnett two-tailed t-test by using Group 1 as the reference control group. PCA demands were analyzed with a Kruskal-Wallis test followed by Wilcoxons rank sum test for multiple comparisons. Discrete variables (sex ratio, sensory block, and side effects) were compared by using
2(2) and Yates correction when appropriate. P < 0.05 was considered significant. Results are expressed as mean ± SD.
| Results |
|---|
|
|
|---|
|
|
Sensory block in the cutaneous distribution of the LFC, femoral, and obturator nerves is presented in Table 3. No significant difference was noted among the groups. In the three groups, LFC and femoral nerve blocks were well maintained during the entire study period. Obturator nerve block was more evanescent, particularly in Group 2.
|
| Discussion |
|---|
|
|
|---|
After unilateral THA, single-dose femoral nerve block (0.5% bupivacaine 40 mL) provided better postoperative analgesia than IV PCA with morphine, but only during the first eight hours after surgery (5). Therefore, different authors have advocated the use of extended femoral nerve sheath block after such surgery (14). In a recent, large-scale (more than 1300 patients), prospective study, we demonstrated that such block is as efficient as IV PCA with morphine or PCEA. Because it induces fewer technical problems and side effects, it is presently the preferred technique (6). This study confirms the analgesic efficiency of extended femoral nerve sheath block after unilateral THA.
A continuous infusion of 0.125% bupivacaine at the rate of 0.14 mL · kg1 · h1 is optimal to maintain extended femoral nerve sheath block (15): neither the extent of anesthesia nor the quality of analgesia is improved by increasing the infusion rate (16). However, this technique leads to the administration of large volumes of local anesthetic with a potential risk of toxicity caused by accumulation of the drug after prolonged periods of infusion (8). In this study, the use of PCA boluses alone provided efficient pain relief and a significant reduction (64% to 73%) in the local anesthetic consumption. Moreover, as expressed by the patients, this technique allowed rapid reinforcement of the block before a hip physiotherapy session. Of the two techniques tested, PCA boluses of five milliliters with a lockout time of 30 minutes were associated with the smallest local anesthetic consumption and the greatest patient satisfaction. It is therefore the recommended extended femoral nerve sheath block technique; however, this technique requires some time to teach the patient. The patient has to learn which pain will be relieved by the catheter (from the anesthetized area) and thus requires a PCA button push, and which pain will not be relieved by the catheter (outside the anesthetized area) and thus requires a nurse call for supplemental parenteral analgesia.
In our study, the extent of anesthesia during extended femoral nerve sheath block varied with time. Although the LFC and femoral nerve blocks were well maintained in the three groups, obturator nerve block was more evanescent, particularly at 48 hours after surgery. Similar results have been obtained by Barthelet et al. (17).
The choice of lockout intervals in our PCA groups was based on experience with PCEA. During PCEA, lockout intervals of at least 15 to 30 minutes are recommended to minimize the possibility of the patient self-administering a bolus dose before the previous dose has had time to exert its analgesic effect (18). Moreover, studies on labor pain relief have shown that the quality of analgesia is unaffected by the duration of the lockout interval as long as effective hourly doses of local anesthetic are administered (19). When considering our previous study during knee surgery (11) and the present one, we can speculate that it would be the same when using a PCA technique for continuous peripheral nerve block. However, further studies are required to confirm this statement.
In accordance with the concept of "balanced analgesia" advocated by Kehlet (20), IV ketorolac was systematically administered to all patients, and clonidine and sufentanil were included in our continuous infusion. When added to the local anesthetic solution, clonidine prolongs the duration of both anesthesia and analgesia after a single-shot brachial plexus block (21). Unpublished data support the same effects during continuous peripheral nerve block. This observation must be confirmed by a large randomized study.
In a recent metaanalysis, Picard et al. (22) concluded that there is no evidence for a clinically significant positive effect of opioids during peripheral nerve blocks. That is why, after the completion of the present study, we no longer add sufentanil to the local anesthetic solution used to maintain extended femoral nerve sheath block. No significant change in the efficiency of the technique was observed.
In this study, there were no complications attributable to the use of PCA techniques. However, the small number of patients does not permit us to make definitive conclusions about its relative safety.
In conclusion, this prospective, randomized, double-blinded study confirmed that, when associated with IV ketorolac, extended femoral nerve sheath block provides efficient pain relief after unilateral THA. It demonstrated that, compared with a continuous infusion, PCA techniques reduce the local anesthetic consumption without compromise in patient satisfaction or VAS scores. Of the two PCA techniques tested, PCA boluses of five milliliters of 0.125% bupivacaine with clonidine 1 µg/mL and sufentanil 0.1 µg/mL with a lockout time of 30 minutes were associated with the smallest local anesthetic consumption and the highest degree of patient satisfaction. It is therefore the recommended technique.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. M. Ilfeld, V. J. Loland, J. C. Gerancher, A. N. Wadhwa, E. M. Renehan, D. I. Sessler, J. J. Shuster, D. W. Theriaque, R. C. Maldonado, E. R. Mariano, et al. The Effects of Varying Local Anesthetic Concentration and Volume on Continuous Popliteal Sciatic Nerve Blocks: A Dual-Center, Randomized, Controlled Study Anesth. Analg., August 1, 2008; 107(2): 701 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brodner, H. Buerkle, H. Van Aken, R. Lambert, M.-L. Schweppe-Hartenauer, C. Wempe, and W. Gogarten Postoperative Analgesia After Knee Surgery: A Comparison of Three Different Concentrations of Ropivacaine for Continuous Femoral Nerve Blockade Anesth. Analg., July 1, 2007; 105(1): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. White The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain Anesth. Analg., November 1, 2005; 101(5S_Suppl): S5 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld and F. K. Enneking Continuous Peripheral Nerve Blocks at Home: A Review Anesth. Analg., June 1, 2005; 100(6): 1822 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weber, R. Fournier, N. Riand, and Z. Gamulin Duration of analgesia is similar when 15, 20, 25 and 30 mL of ropivacaine 0.5% are administered via a femoral catheter: [La duree de l'analgesie est similaire quand 15, 20, 25 et 30 mL de ropivacaine a 0,5 % sont administres par un catheter femoral] Can J Anesth, April 1, 2005; 52(4): 390 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld, T. E. Morey, L. J. Thannikary, T. W. Wright, and F. K. Enneking Clonidine Added to a Continuous Interscalene Ropivacaine Perineural Infusion to Improve Postoperative Analgesia: A Randomized, Double-Blind, Controlled Study Anesth. Analg., April 1, 2005; 100(4): 1172 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. White, T. Issioui, G. D. Skrivanek, J. S. Early, and C. Wakefield The Use of a Continuous Popliteal Sciatic Nerve Block After Surgery Involving the Foot and Ankle: Does It Improve the Quality of Recovery? Anesth. Analg., November 1, 2003; 97(5): 1303 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld, T. E. Morey, and F. K. Enneking Continuous Infraclavicular Perineural Infusion with Clonidine and Ropivacaine Compared with Ropivacaine Alone: A Randomized, Double-Blinded, Controlled Study Anesth. Analg., September 1, 2003; 97(3): 706 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ilfeld, T. E. Morey, X. Capdevila, C. Dadure, N. Bernard, S. Lopez, P. Macaire, and P. Aknin Use of Term "Patient-Controlled" May Be Confusing in Study of Elastometric Pump * Response Anesth. Analg., September 1, 2003; 97(3): 916 - 917. [Full Text] [PDF] |
||||
![]() |
V. Souron, L. Delaunay, and P. Schifrine Intrathecal morphine provides better postoperative analgesia than psoas compartment block after primary hip arthroplasty: [L'administration intrathecale de morphine procure une meilleure analgesie postoperatoire que le bloc du plexus lombaire a la suite d'une arthroplastie primaire de la hanche] Can J Anesth, June 1, 2003; 50(6): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kampe, P. Kiencke, A. Delis, M. Auweiler, D. P. Konig, and S.-M. Kasper The continuous epidural infusion of ropivacaine 0.1% with 0.5 {micro}g*mL-1 sufentanil provides effective postoperative analgesia after total hip replacement: a pilot study: [La perfusion continue de ropivacaine a 0,1 % additionnee de 0,5 {micro}g*mL-1 de sufentanil produit une analgesie postoperatoire efficace apres l'arthroplastie totale de hanche : une etude pilote] Can J Anesth, June 1, 2003; 50(6): 580 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Liu and F. V. Salinas Continuous Plexus and Peripheral Nerve Blocks for Postoperative Analgesia Anesth. Analg., January 1, 2003; 96(1): 263 - 272. [Full Text] [PDF] |
||||
![]() |
X. Capdevila, P. Macaire, C. Dadure, O. Choquet, P. Biboulet, Y. Ryckwaert, and F. d'Athis Continuous Psoas Compartment Block for Postoperative Analgesia After Total Hip Arthroplasty: New Landmarks, Technical Guidelines, and Clinical Evaluation Anesth. Analg., June 1, 2002; 94(6): 1606 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. di Benedetto, A. Casati, L. Bertini, G. Fanelli, and J. E. Chelly Postoperative Analgesia with Continuous Sciatic Nerve Block After Foot Surgery: A Prospective, Randomized Comparison Between the Popliteal and Subgluteal Approaches Anesth. Analg., April 1, 2002; 94(4): 996 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Capdevila, P. Biboulet, D. Morau, N. Bernard, J. Deschodt, S. Lopez, and F. d'Athis Continuous Three-in-One Block for Postoperative Pain After Lower Limb Orthopedic Surgery: Where Do the Catheters Go? Anesth. Analg., April 1, 2002; 94(4): 1001 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kampe and F. Singelyn Extended Femoral Nerve Sheath Block After Total Hip Arthroplasty Response Anesth. Analg., September 1, 2001; 93(3): 804 - 804. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|